11606

509079

GUFICBIO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GUFIC BIOSCIENCES LTD. Share Price Today

GUFIC BIOSCIENCES LTD. is currently trading at ₹366.85, down by ₹3.39 from the previous close. The stock touched an intraday high of ₹377.45 and a low of ₹363.90 during the latest trading session. Over the past one year, GUFIC BIOSCIENCES LTD. has delivered a return of 4.07%, while the stock has gained 22.71% in the last one month.

GUFIC BIOSCIENCES LTD. performance

Today’s low Today’s high
₹ 363.90 ₹ 377.45
₹ 364.85
52 week low 52 week high
₹ 268.00 ₹ 407.85
₹ 364.85
Open Price ₹ 370.85
Prev. Close ₹ 370.25
Volume (Shares) 63687.00
Total traded value ₹ 232.36
Upper Circuit ₹ 444.30
Lower Circuit ₹ 296.20
info

Investment Returns

Over 1 Month 22.71% Over 3 Months 28.05% Over 6 Months 4.38% Over 1 Year 4.07%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

GUFIC BIOSCIENCES LTD. fundamentals


  • Market cap (Cr) 3,638.80
  • P/E Ratio (TTM) 57.40
  • Beta 0.83
  • Book Value / share 66.23
  • Return on equity 12.33%
  • EPS (TTM) 6.30
  • Dividend yield 0.03%
  • Net profit/quarter (Cr) 20.57
info icon alternate text
  • Market cap (Cr) 3,649.80
  • P/E Ratio (TTM) 57.40
  • Beta 0.87
  • Book Value / share 66.23
  • Return on equity 12.33%
  • EPS (TTM) 6.30
  • Dividend yield 0.03%
  • Net profit/quarter (Cr) 20.57
info icon alternate text

GUFIC BIOSCIENCES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 252.05
Operating Expense 223.23
Net Profit 20.57
Net Profit Margin (%) 8.16
Earnings Per Share (EPS) 2.05
EBITDA 44.72
Effective Tax Rate (%) 25.51
Particulars DEC 2025 (Values in Cr)
Revenue 231.09
Operating Expense 210.83
Net Profit 15.56
Net Profit Margin (%) 6.73
Earnings Per Share (EPS) 1.55
EBITDA 37.10
Effective Tax Rate (%) 26.08
Particulars SEP 2025 (Values in Cr)
Revenue 230.42
Operating Expense 211.98
Net Profit 14.94
Net Profit Margin (%) 6.48
Earnings Per Share (EPS) 1.49
EBITDA 37.87
Effective Tax Rate (%) 27.22
Particulars JUN 2025 (Values in Cr)
Revenue 226.91
Operating Expense 211.53
Net Profit 12.07
Net Profit Margin (%) 5.31
Earnings Per Share (EPS) 1.20
EBITDA 33.23
Effective Tax Rate (%) 25.79
Particulars MAR 2025 (Values in Cr)
Revenue 205.02
Operating Expense 194.62
Net Profit 7.97
Net Profit Margin (%) 3.88
Earnings Per Share (EPS) 0.80
EBITDA 27.02
Effective Tax Rate (%) 26.06
Particulars MAR 2026 (Values in Cr)
Revenue 940.48
Operating Expense 857.57
Net Profit 63.15
Net Profit Margin (%) 6.71
Earnings Per Share (EPS) 6.30
EBITDA 152.93
Effective Tax Rate (%) 26.13
Particulars MAR 2025 (Values in Cr)
Revenue 819.81
Operating Expense 728.99
Net Profit 69.93
Net Profit Margin (%) 8.53
Earnings Per Share (EPS) 6.97
EBITDA 140.01
Effective Tax Rate (%) 25.93
Particulars MAR 2024 (Values in Cr)
Revenue 806.67
Operating Expense 693.17
Net Profit 86.14
Net Profit Margin (%) 10.67
Earnings Per Share (EPS) 8.74
EBITDA 148.05
Effective Tax Rate (%) 25.53
Particulars MAR 2023 (Values in Cr)
Revenue 690.62
Operating Expense 586.47
Net Profit 79.70
Net Profit Margin (%) 11.54
Earnings Per Share (EPS) 8.22
EBITDA 137.22
Effective Tax Rate (%) 25.31
Particulars MAR 2022 (Values in Cr)
Revenue 779.16
Operating Expense 655.43
Net Profit 95.84
Net Profit Margin (%) 12.30
Earnings Per Share (EPS) 9.89
EBITDA 151.14
Effective Tax Rate (%) 24.44
Particulars MAR 2025 (Values in Cr)
Book Value / Share 59.93
ROE % 12.29
ROCE % 12.86
Total Debt to Total Equity 0.59
EBITDA Margin 17.04
Particulars MAR 2024 (Values in Cr)
Book Value / Share 53.11
ROE % 16.17
ROCE % 14.95
Total Debt to Total Equity 0.63
EBITDA Margin 18.53
Particulars MAR 2025 (Values in Cr)
Book Value / Share 59.96
ROE % 12.33
ROCE % 12.88
Total Debt to Total Equity 0.59
EBITDA Margin 17.08
Particulars MAR 2024 (Values in Cr)
Book Value / Share 53.11
ROE % 19.57
ROCE % 16.70
Total Debt to Total Equity 0.76
EBITDA Margin 18.53
Particulars MAR 2023 (Values in Cr)
Book Value / Share 35.88
ROE % 25.84
ROCE % 21.87
Total Debt to Total Equity 0.65
EBITDA Margin 19.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share 27.76
ROE % 43.31
ROCE % 43.99
Total Debt to Total Equity 0.28
EBITDA Margin 19.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 17.89
ROE % 29.22
ROCE % 27.51
Total Debt to Total Equity 0.62
EBITDA Margin 17.97
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 29.02
Total Assets 1169.36
Total Liabilities 1169.36
Total Equity 601.07
Share Outstanding 10
Price to Book Ratio 5.61
Return on Assets (%) 5.95
Return on Capital (%) 7.64
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.48
Total Assets 1092.54
Total Liabilities 1092.54
Total Equity 532.56
Share Outstanding 10
Price to Book Ratio 5.33
Return on Assets (%) 7.88
Return on Capital (%) 10.14
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 28.20
Total Assets 1169.62
Total Liabilities 1169.62
Total Equity 601.36
Share Outstanding 10
Price to Book Ratio 5.61
Return on Assets (%) 5.97
Return on Capital (%) 7.67
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.47
Total Assets 1092.54
Total Liabilities 1092.54
Total Equity 532.56
Share Outstanding 10
Price to Book Ratio 5.33
Return on Assets (%) 7.88
Return on Capital (%) 10.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 46.68
Total Assets 861.15
Total Liabilities 861.15
Total Equity 347.80
Share Outstanding 9
Price to Book Ratio 5.20
Return on Assets (%) 9.25
Return on Capital (%) 12.09
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 26.57
Total Assets 521.40
Total Liabilities 521.40
Total Equity 269.11
Share Outstanding 9
Price to Book Ratio 8.97
Return on Assets (%) 18.38
Return on Capital (%) 29.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 13.17
Total Assets 392.06
Total Liabilities 392.06
Total Equity 173.43
Share Outstanding 9
Price to Book Ratio 6.39
Return on Assets (%) 11.28
Return on Capital (%) 19.33
Particulars MAR 2025 (Values in Cr)
Net Income 69.64
Cash from Operations 145.37
Cash from Investing -70.77
Cash from Financing -37.20
Net change in Cash 14.58
Free Cash Flow 145.37
Particulars MAR 2024 (Values in Cr)
Net Income 86.13
Cash from Operations 19.58
Cash from Investing -102.38
Cash from Financing 82.38
Net change in Cash -27.46
Free Cash Flow 19.58
Particulars MAR 2025 (Values in Cr)
Net Income 69.93
Cash from Operations 145.58
Cash from Investing -71.79
Cash from Financing -37.20
Net change in Cash 13.78
Free Cash Flow 145.58
Particulars MAR 2024 (Values in Cr)
Net Income 86.13
Cash from Operations 19.58
Cash from Investing -102.39
Cash from Financing 82.38
Net change in Cash -27.47
Free Cash Flow 19.58
Particulars MAR 2023 (Values in Cr)
Net Income 79.70
Cash from Operations 1.10
Cash from Investing -190.72
Cash from Financing 234.30
Net change in Cash 16.99
Free Cash Flow 1.10
Particulars MAR 2022 (Values in Cr)
Net Income 95.84
Cash from Operations 139.29
Cash from Investing -94.58
Cash from Financing -6.24
Net change in Cash 5.40
Free Cash Flow 139.29
Particulars MAR 2021 (Values in Cr)
Net Income 44.23
Cash from Operations 96.65
Cash from Investing -6.69
Cash from Financing -78.61
Net change in Cash 1.94
Free Cash Flow 109.05
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.60 13.06 1.52 242.16 23.12 38.85
BLISS GVS PHARMA LTD. 473.30 38.42 4.20 5019.64 118.35 493.70
CIPLA LTD 1415.30 30.04 3.32 114334.35 1165.55 1672.20
FERMENTA BIOTECH LTD. 341.80 15.08 2.47 1005.95 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.60 22.10 4.07 242.16 23.12 38.85
AMRUTAJAN HEALTH LTD 546.80 24.51 4.26 1580.83 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8556.55 111.75 24.50 21391.38 7630.00 9850.00
BLISS GVS PHARMA LTD. 473.30 51.06 4.34 5019.64 118.35 493.70

GUFIC BIOSCIENCES LTD. shareholding pattern

Holding
23.24%
72.5%
0.42%
3.83%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

GUFIC BIOSCIENCES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
362.85 0.67 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 360.60
  • 26 Days 344.60
  • 10 Days 360.10
  • 50 Days 328.70
  • 12 Days 358.70
  • 100 Days 320.20
  • 20 Days 350.60
  • 200 Days 327.30
360.97 PIVOT
First Support 354.53 First Resistance 366.83 Second Support 348.67 Second Resistance 373.27 Third Support 342.23 Third Resistance 379.13
RSI 57.56 ADX 57.20 MACD 14.08 Williams % R -68.82 Commodity Channel Index (CCI) 24.55
Date 2026-06-22 Week 38548.00 Same Day 33238.00 Month 79446.00
1 Year 0.84 3 Year 0.80
Over 1 Month
22.71% down
Over 1 Year
4.07% down
Over 3 Months
28.05% down
Over 3 Years
16.59% down
Over 6 Months
4.38% down
Over 5 Years
15.88% down

GUFIC BIOSCIENCES LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
22 Sep 2025 0.1 Final 22 Sep 2025 Equity shares
17 Sep 2024 0.1 Final 19 Sep 2024 Equity shares
21 Sep 2023 0.1 Final 21 Sep 2023 Equity shares
24 Aug 2022 0.1 Final 25 Aug 2022 Equity shares
09 Sep 2021 0.1 Final 14 Sep 2021 Equity shares
03 Nov 2020 0.05 Final 05 Nov 2020 Equity shares
20 Sep 2019 0.05 Final 24 Sep 2019 Equity shares
19 Sep 2018 0.05 Final 22 Sep 2018 Equity shares
28 Aug 2017 0.05 Final 30 Aug 2017 Equity shares
19 Sep 2016 0.05 Final 21 Sep 2016 Equity shares
22 Sep 2015 0.05 Final 24 Sep 2015 Equity shares
18 Sep 2014 0.05 Final 22 Sep 2014 Equity shares
02 Sep 2013 0.05 Final 23 Sep 2013 Equity shares
16 Aug 2012 0.05 Final 20 Aug 2012 Equity shares
16 Sep 2011 0.05 Final 20 Sep 2011 Equity shares
20 Sep 2010 0.05 Final 22 Sep 2010 Equity shares
17 Sep 2009 0.05 Final 19 Sep 2009 Equity shares
11 Dec 2008 0.05 Final 15 Dec 2008 Equity shares
19 Mar 2008 0.05 Final 25 Mar 2008 Equity shares
20 Sep 2006 0.0 Final 22 Sep 2006 Equity shares
22 Sep 2005 0.0 Final 24 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
04 Nov 2000 19 Oct 2000 5:2
04 Nov 2000 09 Oct 2000 5:2
Ex-Date Old FV NEW FV Record Date
29 Oct 2002 10.0 1.0 08 Nov 2002
Dividend date Dividend amount Dividend type Record date Instrument type
22 Sep 2025 0.1 Final 22 Sep 2025 Equity shares
17 Sep 2024 0.1 Final 19 Sep 2024 Equity shares
21 Sep 2023 0.1 Final 21 Sep 2023 Equity shares
24 Aug 2022 0.1 Final 25 Aug 2022 Equity shares
09 Sep 2021 0.1 Final 14 Sep 2021 Equity shares
03 Nov 2020 0.05 Final 05 Nov 2020 Equity shares
20 Sep 2019 0.05 Final 24 Sep 2019 Equity shares
19 Sep 2018 0.05 Final 22 Sep 2018 Equity shares
28 Aug 2017 0.05 Final 30 Aug 2017 Equity shares
19 Sep 2016 0.05 Final 21 Sep 2016 Equity shares
22 Sep 2015 0.05 Final 24 Sep 2015 Equity shares
18 Sep 2014 0.05 Final 22 Sep 2014 Equity shares
02 Sep 2013 0.05 Final 23 Sep 2013 Equity shares
16 Aug 2012 0.05 Final 20 Aug 2012 Equity shares
16 Sep 2011 0.05 Final 20 Sep 2011 Equity shares
20 Sep 2010 0.05 Final 22 Sep 2010 Equity shares
17 Sep 2009 0.05 Final 19 Sep 2009 Equity shares
11 Dec 2008 0.05 Final 15 Dec 2008 Equity shares
19 Mar 2008 0.05 Final 25 Mar 2008 Equity shares
20 Sep 2006 0.0 Final 22 Sep 2006 Equity shares
22 Sep 2005 0.0 Final 24 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
04 Nov 2000 19 Oct 2000 5:2
04 Nov 2000 09 Oct 2000 5:2
Ex-Date Old FV NEW FV Record Date
29 Oct 2002 10.0 1.0 08 Nov 2002

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Gufic BioSciences Ltd?

Answer Field

Gufic BioSciences Ltd share price is for NSE ₹ 366.85 & for BSE ₹ 367.90 as on Jun 24 2026 01:51 PM.

What is the Market Cap of Gufic BioSciences Ltd Share?

Answer Field

The market cap of Gufic BioSciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 24 2026 01:51 PM.

What is the 52 Week High and Low of Gufic BioSciences Ltd?

Answer Field

The 52 Week High and Low of Gufic BioSciences Ltd for NSE is ₹ 407.85 and ₹ 268.00 and for BSE is ₹ 409.00 and ₹ 267.50.

What is 1 year return for Gufic BioSciences Ltd?

Answer Field

The 1 year returns on the stock has been 4.07%.

What is the P/E Ratio of Gufic BioSciences Ltd Share?

Answer Field

As on Jun 24 2026 01:51 PM the price-to-earnings (PE) ratio for Gufic BioSciences Ltd share is 57.40.

What is the PB ratio of Gufic BioSciences Ltd Share?

Answer Field

As on Jun 24 2026 01:51 PM, the price-to-book (PB) ratio for Gufic BioSciences Ltd share is 66.23.

How to Buy Gufic BioSciences Ltd Share?

Answer Field

You can trade in Gufic BioSciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gufic BioSciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Gufic BioSciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gufic BioSciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|